Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 8-K Event Executive or director change
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. 10-Q Report Quarterly Report
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. SC 13D Stake Beneficial Ownership Report
  14. SC 13D Stake Beneficial Ownership Report
  15. D Other Notice of Sales of Unregistered Securities
  16. 4 Conversion Director acquired 1,049,055 shares (conversion)
  17. 4 Conversion Chief Operating Officer acquired 3,746 shares (conversion)
  18. 4 Open-market buy Director bought 733,333 shares at $15.00 ($10,999,995)
  19. 4 Conversion Director acquired 4,793 shares (conversion)
  20. 4 Conversion Chief Executive Officer acquired 13,931 shares (conversion)

Page 16 of 18 · 353 filings